Savitz Ryan
Reporting owner on Forms 3, 4 and 5, CIK 1992324.
Savitz Ryan reported on 1 issuer in 1 filing, the latest a Form 4 filed 2026-11-12.
Issuers
| Issuer | Roles in the latest filing | Filings | Last filed |
|---|---|---|---|
| DNTH · Dianthus Therapeutics, Inc. /DE/CIK 1690585 | officer (EVP, CFO & CBO) | 1 | 2026-11-12 |
Transactions and holdings
Every row of the person's Forms 3, 4 and 5, newest first, with the price and the amount owned after the row as filed.
| Security | Date | Code | Shares | Price | Owned after | Filing |
|---|---|---|---|---|---|---|
| DNTH · Dianthus Therapeutics, Inc.…Common Stock | 2026-11-12 | M exercised | +1,339 | $21.77 | 1,339 | Form 4 |
| DNTH · Dianthus Therapeutics, Inc.…Common Stock | 2026-11-12 | M exercised | +16,385 | $22.07 | 17,724 | Form 4 |
| DNTH · Dianthus Therapeutics, Inc.…Common Stock | 2026-11-12 | S sold | -17,724 | $90.56 | 0 | Form 4 |
| DNTH · Dianthus Therapeutics, Inc.…Stock Option (Right to Buy), derivative | 2026-11-12 | M exercised | -1,339 | $0 | 43,759 | Form 4 |
| DNTH · Dianthus Therapeutics, Inc.…Stock Option (Right to Buy), derivative | 2026-11-12 | M exercised | -16,385 | $0 | 90,625 | Form 4 |
| DNTH · Dianthus Therapeutics, Inc.…Common Stock | 2026-11-11 | M exercised | +1,744 | $21.77 | 1,744 | Form 4 |
| DNTH · Dianthus Therapeutics, Inc.…Common Stock | 2026-11-11 | M exercised | +1,300 | $22.07 | 3,044 | Form 4 |
| DNTH · Dianthus Therapeutics, Inc.…Common Stock | 2026-11-11 | S sold | -3,044 | $90.03 | 0 | Form 4 |
| DNTH · Dianthus Therapeutics, Inc.…Stock Option (Right to Buy), derivative | 2026-11-11 | M exercised | -1,744 | $0 | 45,098 | Form 4 |
| DNTH · Dianthus Therapeutics, Inc.…Stock Option (Right to Buy), derivative | 2026-11-11 | M exercised | -1,300 | $0 | 107,010 | Form 4 |
| DNTH · Dianthus Therapeutics, Inc.…Common Stock | 2026-11-10 | M exercised | +1,301 | $21.77 | 1,301 | Form 4 |
| DNTH · Dianthus Therapeutics, Inc.…Common Stock | 2026-11-10 | M exercised | +1,260 | $22.07 | 2,561 | Form 4 |
| DNTH · Dianthus Therapeutics, Inc.…Common Stock | 2026-11-10 | S sold | -2,561 | $90.14 | 0 | Form 4 |
| DNTH · Dianthus Therapeutics, Inc.…Stock Option (Right to Buy), derivative | 2026-11-10 | M exercised | -1,301 | $0 | 46,842 | Form 4 |
| DNTH · Dianthus Therapeutics, Inc.…Stock Option (Right to Buy), derivative | 2026-11-10 | M exercised | -1,260 | $0 | 108,310 | Form 4 |
| DNTH · Dianthus Therapeutics, Inc.…Common Stock | 2026-11-09 | M exercised | +29,276 | $17.88 | 29,276 | Form 4 |
| DNTH · Dianthus Therapeutics, Inc.…Common Stock | 2026-11-09 | M exercised | +20,608 | $21.77 | 49,884 | Form 4 |
| DNTH · Dianthus Therapeutics, Inc.…Common Stock | 2026-11-09 | M exercised | +40,430 | $22.07 | 90,314 | Form 4 |
| DNTH · Dianthus Therapeutics, Inc.…Common Stock | 2026-11-09 | M exercised | +10,399 | $8.44 | 100,713 | Form 4 |
| DNTH · Dianthus Therapeutics, Inc.…Common Stock | 2026-11-09 | S sold | -300 | $85.16 | 100,413 | Form 4 |
| DNTH · Dianthus Therapeutics, Inc.…Common Stock | 2026-11-09 | S sold | -700 | $86.7 | 99,713 | Form 4 |
| DNTH · Dianthus Therapeutics, Inc.…Common Stock | 2026-11-09 | S sold | -1,736 | $88.84 | 97,977 | Form 4 |
| DNTH · Dianthus Therapeutics, Inc.…Common Stock | 2026-11-09 | S sold | -37,517 | $90.12 | 60,460 | Form 4 |
| DNTH · Dianthus Therapeutics, Inc.…Common Stock | 2026-11-09 | S sold | -58,396 | $90.9 | 2,064 | Form 4 |
| DNTH · Dianthus Therapeutics, Inc.…Common Stock | 2026-11-09 | S sold | -2,064 | $91.59 | 0 | Form 4 |
| DNTH · Dianthus Therapeutics, Inc.…Stock Option (Right to Buy), derivative | 2026-11-09 | M exercised | -29,276 | $0 | 42,500 | Form 4 |
| DNTH · Dianthus Therapeutics, Inc.…Stock Option (Right to Buy), derivative | 2026-11-09 | M exercised | -20,608 | $0 | 48,143 | Form 4 |
| DNTH · Dianthus Therapeutics, Inc.…Stock Option (Right to Buy), derivative | 2026-11-09 | M exercised | -40,430 | $0 | 109,570 | Form 4 |
| DNTH · Dianthus Therapeutics, Inc.…Stock Option (Right to Buy), derivative | 2026-11-09 | M exercised | -10,399 | $0 | 0 | Form 4 |
Filings
The person's Forms 3, 4 and 5, and any 13D or 13G naming it.
| Filing | Subject | Filed | Accepted | Ingested |
|---|---|---|---|---|
| Form 4 0001992324-26-000010 | Dianthus Therapeutics, Inc. /DE/ | 2026-11-12 |